NEOGEN director Pelossof receives 20,558 options
Both awards vest in equal annual installments on each of the first three grant anniversaries.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Avi Pelossof, a director of NEOGEN Corp., received an award of options covering 20,558 common shares at a $12.24 exercise price and 9,804 restricted stock units on October 1, 2026. His reported direct positions after the awards were 20,558 options and 9,804 restricted stock units. Both awards vest in equal annual installments on each of the first three grant anniversaries; the options expire October 1, 2036.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock (Right to Buy) F1 | 20,558 | $0.00 | $0.00 |
| Grant/Award | Restricted Stock Units F1 | 9,804 | $12.24 | $120K |
Footnotes (1)
- F1. Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants
Key Figures
Key Terms
Restricted Stock Units financial
Options financial
annual installments financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What awards did NEOG director Avi Pelossof receive?
When do Avi Pelossof's NEOG awards vest, and when do the options expire?
AI-generated analysis. How Rhea-AI works. Not financial advice.